Dr. Delev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
836 W Wellington Ave
Room 7304
Chicago, IL 60657Phone+1 773-296-7046
Education & Training
- Johns Hopkins UniversityFellowship, Rheumatology, 2009 - 2011
- Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 2006 - 2009
- Medical University of Sofia FOMClass of 2003
Certifications & Licensure
- VA State Medical License 2012 - 2024
- NJ State Medical License 2012 - 2023
- IL State Medical License 2006 - 2014
- MD State Medical License 2012 - 2014
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Publications & Presentations
PubMed
- 12 citationsIberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study.Richard A Furie, Douglas R Hough, Allison Gaudy, Ying Ye, Shimon Korish
Lupus Science & Medicine. 2022-02-01 - 74 citationsDeucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.Eric Morand, Marilyn Pike, Joan T Merrill, Ronald van Vollenhoven, Victoria P Werth
Arthritis & Rheumatology. 2023-02-01 - 27 citationsTherapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studiesDafna D. Gladman, Arthur Kavanaugh, Juan J. Gomez-Reino, Jürgen Wollenhaupt, Maurizio Cutolo
RMD Open. 2018-06-01
Press Mentions
- New Lupus Partnership with FDA Aims to End Drug Trials’ History of FailureMarch 29th, 2023
Industry Relationships
- Executive Medical Director, BMS
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: